Sensible Biotechnologies
A platform for designing and manufacturing naturally modified mRNA medicines.
$47MSeries A
ParticipantCV
Civilization Ventures
Activity from announced rounds
Activity in this selectionOct 16, 2026 · Jul 19, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $122M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionInfinimmune
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
$75MSeries A
Role not disclosed